Skip to content
USAID: From The American People TB-DIAH: Tuberculosis Data, Impact Assessment and Communications Hub
  • Knowledge Hub
  • Data Hub
  • Home
  • About
    • Project Overview & Objectives
    • TB DIAH Team
  • Countries
    • Afghanistan
    • Bangladesh
    • Burma
    • Cambodia
    • DRC
    • Ethiopia
    • India
    • Indonesia
    • Kenya
    • Kyrgyz Republic
    • Malawi
    • Mozambique
    • Nigeria
    • Pakistan
    • Philippines
    • South Africa
    • Tajikistan
    • Tanzania
    • Uganda
    • Ukraine
    • Uzbekistan
    • Vietnam
    • Zambia
    • Zimbabwe
  • Tools
    • ARCAssessment of Data Collection, Reporting & Analysis Capacity
    • D2ACData-to-Action Continuum Toolkit
    • MESSAM&E and Surveillance Systems Assessment
    • PBMEFPerformance-Based M&E Framework
    • QTSAQuality of Tuberculosis Services Assessment
    • STEPSurveillance and TB M&E Strengthening Plan
  • Resources
    • Capacity Strengthening
    • Center of Excellence
    • e-Learning Courses
    • NTP Website Activity
    • Resource Library
  • News
    • TB DIAH Digest
    • Social Media
    • 2023 Union Conference
    • Webinars

Resource Tag: Diagnostics

Clinical Management of TB/HIV Coinfection

Clinical Management of TB/HIV Coinfection
Author(s): Pan American Health Organization
Year: 2023
Filed under: clinical, clinical management, clinical TB, Coinfection, Course, Diagnosis, diagnostic, Diagnostics, e-course, e-learning, HIV, infection, learning, PAHO, pan american, pan american health organization, Prevention, Public Health, TB, Treatment, Tuberculosis
Continue Reading

Лекарственно-устойчивый туберкулез: интерпретация результатов быстрых молекулярных тестов

Лекарственно-устойчивый туберкулез: интерпретация результатов быстрых молекулярных тестов
Author(s): WHO
Filed under: clinical, Course, Diagnosis, Diagnostics, DR-TB, drug resistance, Drug susceptibility testing, Drug-resistant TB, DST, e-course, e-learning, GeneXpert, Guidance and Tools, learning, rapid, rapid diagnostics, rapid molecular test, rapid test, Russian, TB, Toolkit, Training, Tuberculosis, WHO, World Health Organization
Continue Reading

Drug-resistant tuberculosis: how to interpret rapid molecular test results

Drug-resistant tuberculosis: how to interpret rapid molecular test results
Author(s): WHO
Filed under: clinical, Course, Diagnosis, Diagnostics, DR-TB, drug resistance, Drug susceptibility testing, Drug-resistant TB, DST, e-course, e-learning, GeneXpert, Guidance and Tools, learning, rapid, rapid diagnostics, rapid molecular test, rapid test, TB, Toolkit, Training, Tuberculosis, WHO, World Health Organization
Continue Reading

Rapid diagnostics for tuberculosis detection

Rapid diagnostics for tuberculosis detection
Author(s): WHO
Filed under: Course, Diagnosis, Diagnostics, Drug susceptibility testing, e-course, e-learning, learning, rapid, rapid diagnostics, Rapid tests, TB, Treatment, Tuberculosis, WHO, World Health Organization
Continue Reading

Comparison of Survey Results to Evaluate the Availability, Readiness, and Quality of the Uganda Tuberculosis Diagnosis Network

Comparison of Survey Results to Evaluate the Availability, Readiness, and Quality of the Uganda Tuberculosis Diagnosis Network
Author(s): TB DIAH
Year: 2021
Filed under: assessement, Diagnosis, Diagnostics, Evaluation, National TB programs, network, Prevention, QTSA, Report, TB data, Treatment, Uganda
Continue Reading

Generic “New Drugs and the Shorter Treatment Regimen” Training Modules

Year: 2019
Filed under: Diagnostics, DR-TB, Drug-resistant TB, Guidance and Tools, NTP, TB care, Training, Treatment
Continue Reading

Framework of indicators and targets for laboratory strengthening under the End TB Strategy

Framework of indicators and targets for laboratory strengthening under the End TB Strategy
Author(s): World Health Organization
Year: 2016
Filed under: Diagnostics, End TB, Framework, Guidance and Tools, Indicators, Targets
Continue Reading

Potential of nanotechnology as a delivery platform against tuberculosis: Current research review

Potential of nanotechnology as a delivery platform against tuberculosis: Current research review
Author(s): Journal of Controlled Release
Year: 2015
Filed under: Diagnostics, Journal Article, Research, Technology, Tuberculosis
Continue Reading

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines
Author(s): Clinical Infectious Diseases
Year: 2015
Filed under: Diagnostics, Journal Article, mdr-tb, multidrug-resistant TB, Rapid tests, Research, Treatment, XDR-TB
Continue Reading

Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests

Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests
Author(s): BMC Health Services Research
Year: 2015
Filed under: Diagnostics, GenoType, Journal Article, mdr-tb, multidrug-resistant TB, Qualitative, Rapid tests, Research, Tests, Treatment, Xpert
Continue Reading

Posts navigation

Older Posts
  • Knowledge Hub
  • Data Hub
TB DIAH Project
University of North Carolina
123 West Franklin Street, Suite 330
Chapel Hill, North Carolina 27516 USA
About
Countries
Topics
Resource Library
News
TB DIAH Digest
Special Features
Assessments
TB Data Hub
Objectives

The TB DIAH project is part of USAID's performance-based measures to end TB—the Global Accelerator to End Tuberculosis. This TB DIAH website features a data hub, guidance, and tools to support the work of the global TB community. TB DIAH makes possible optimal analysis and use of TB data to inform national TB programs, policies, and USAID-supported interventions.

This information was produced with the support of the United States Agency for International Development (USAID) under the terms of the TB Data, Impact Assessment and Communications Hub (TB DIAH) Associate Award No. 7200AA18LA00007. TB DIAH is implemented by the University of North Carolina at Chapel Hill, in partnership with John Snow, Inc. Views expressed are not necessarily those of USAID or the United States government.